TY - JOUR
T1 - Frailty and Biomarkers of Frailty Predict Outcome in Veterans After Open and Endovascular Revascularization
AU - Gonzalez, Lorena
AU - Kassem, Mohammed
AU - Owora, Arthur H.
AU - Seligson, Marc T.
AU - Richards, Camille Y.
AU - Monita, Monique M.
AU - Cardounell, Sylvia Z.
AU - Brangman, Sharon A.
AU - Gahtan, Vivian
N1 - Funding Information:
Authors' contributions: L.G. is the primary author of this manuscript. L.G. developed the study idea and design, assisted with data collection, participated in data analysis, and wrote the manuscript. M.K. collected the majority of data and assisted with manuscript writing, specifically the methodology. C.Y.R. and M.T.S. participated in data collection and manuscript editing. S.C. and M.M. created the patient database, completed the preliminary screening of charts for patient selection, and assisted with data collection. They also participated in manuscript editing. A.H.O. performed the statistical analysis for the study and participated in the writing of the manuscript, specifically the statistical analysis and results sections. Finally, S.A.B. and V.G. served as co-investigators in this project, assisted with study design and data analysis, and participated in manuscript editing.
Publisher Copyright:
© 2019
PY - 2019/11
Y1 - 2019/11
N2 - Background: Frailty predicts poor outcome after vascular surgery. We determined the predictive utility of the modified frailty index (mFI) after first-time revascularization and identified biomarkers of frailty predictive of outcome in veterans with peripheral arterial disease. Methods: A retrospective study was performed of first-time revascularizations (open surgery [OS] and endovascular surgery [ES]) in male veterans (2003-2016). Preoperative mFI scores were calculated, and serum and nonserum biomarkers of frailty were recorded. The primary endpoint was 2-y incidence of reintervention, amputation, and mortality. Secondary endpoints included 30-day morbidity and readmissions. Results: Four hundred and thirty one patients (OS, n = 188; ES, n = 243), mean age of 66 ± 9 y, and 16 mo of median follow-up were studied. Mean mFI was 0.39 ± 0.16 for OS and 0.38 ± 0.15 for ES (P = 0.43). 30-day complications (adjusted odds ratio, 4.89; 95% confidence interval [CI]: 1.67-14.33) and readmissions (adjusted hazard ratio [aHR] 3.32; 95% CI: 1.16-9.55) were increased in the OS versus ES group when stratified by mFI. Survival analysis showed a correlation between risk of amputation, death, and composite outcome with increasing mFI (P < 0.005) in both groups. Frailty independently predicted major amputation (aHR 2.16; 1.06-4.39), mortality (aHR 2.62; 95% CI: 1.17-5.88), and composite outcome (aHR 1.97; 95% CI: 1.06-3.68) when the groups are combined. Except for absolute neutrophil count, all preoperative lab values correlated with mFI (P < 0.5). Higher albumin was independently associated with lower risk of amputation (aHR: 0.58 [0.36-0.94]) and mortality (aHR: 0.45 [0.25-0.83]); higher hemoglobin predicted limb salvage (aHR 0.7 [0.62-0.84]). Conclusions: Frailty predicts short- and long-term outcomes after first-time revascularization in veterans. Hypoalbuminemia and anemia are associated with higher mFI and independently predict poor outcome, suggesting albumin and hemoglobin are viable biomarkers of frailty in veterans.
AB - Background: Frailty predicts poor outcome after vascular surgery. We determined the predictive utility of the modified frailty index (mFI) after first-time revascularization and identified biomarkers of frailty predictive of outcome in veterans with peripheral arterial disease. Methods: A retrospective study was performed of first-time revascularizations (open surgery [OS] and endovascular surgery [ES]) in male veterans (2003-2016). Preoperative mFI scores were calculated, and serum and nonserum biomarkers of frailty were recorded. The primary endpoint was 2-y incidence of reintervention, amputation, and mortality. Secondary endpoints included 30-day morbidity and readmissions. Results: Four hundred and thirty one patients (OS, n = 188; ES, n = 243), mean age of 66 ± 9 y, and 16 mo of median follow-up were studied. Mean mFI was 0.39 ± 0.16 for OS and 0.38 ± 0.15 for ES (P = 0.43). 30-day complications (adjusted odds ratio, 4.89; 95% confidence interval [CI]: 1.67-14.33) and readmissions (adjusted hazard ratio [aHR] 3.32; 95% CI: 1.16-9.55) were increased in the OS versus ES group when stratified by mFI. Survival analysis showed a correlation between risk of amputation, death, and composite outcome with increasing mFI (P < 0.005) in both groups. Frailty independently predicted major amputation (aHR 2.16; 1.06-4.39), mortality (aHR 2.62; 95% CI: 1.17-5.88), and composite outcome (aHR 1.97; 95% CI: 1.06-3.68) when the groups are combined. Except for absolute neutrophil count, all preoperative lab values correlated with mFI (P < 0.5). Higher albumin was independently associated with lower risk of amputation (aHR: 0.58 [0.36-0.94]) and mortality (aHR: 0.45 [0.25-0.83]); higher hemoglobin predicted limb salvage (aHR 0.7 [0.62-0.84]). Conclusions: Frailty predicts short- and long-term outcomes after first-time revascularization in veterans. Hypoalbuminemia and anemia are associated with higher mFI and independently predict poor outcome, suggesting albumin and hemoglobin are viable biomarkers of frailty in veterans.
KW - Amputation
KW - Biomarkers
KW - Frailty
KW - PAD
KW - Revascularization
KW - Veteran
UR - http://www.scopus.com/inward/record.url?scp=85069975781&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069975781&partnerID=8YFLogxK
U2 - 10.1016/j.jss.2019.06.040
DO - 10.1016/j.jss.2019.06.040
M3 - Article
AN - SCOPUS:85069975781
SN - 0022-4804
VL - 243
SP - 539
EP - 552
JO - Journal of Surgical Research
JF - Journal of Surgical Research
ER -